Enzymatica AB

Enzymatica AB is a biotechnology company that develops medical device products utilizing its proprietary enzyme technology. The company's primary function is to create healthcare products aimed at preventing, treating, and alleviating viral infections and inflammatory conditions. Enzymatica's products typically harness cold-adapted enzymes to enhance their efficacy in various healthcare solutions, particularly within the respiratory health segment. One of its notable products is ColdZyme, a mouth spray designed to protect against the common cold by forming a protective barrier on the mucous membrane of the throat. Operating primarily in the pharmaceutical and biotechnology sectors, Enzymatica AB plays a crucial role in innovating non-prescription therapeutic solutions that offer preventative care and symptom relief. The company maintains its market significance by addressing prevalent health issues and leveraging biotechnological advances to offer consumers effective healthcare products. Headquartered in Sweden, Enzymatica's reach extends globally, allowing it to impact health and wellness on an international scale through strategic partnerships and distribution networks.